Case-reporting of acute hepatitis B and C among injection drug users

Holly Hagan, Nadine Snyder, Eileen Hough, Tianji Yu, Shelly McKeirnan, Janice Boase, Jeffrey Duchin

Research output: Contribution to journalArticle

Abstract

Although public health surveillance system data are widely used to describe the epidemiology of communicable disease, occurrence of hepatitis B and C virus (HBV and HCV, respectively) infections may be misrepresented by under-reporting in injection drug users (IDUs). This study was carried out to examine the relationship between HBV and HCV incidence and case-reporting of hepatitis B and C in Seattle IDUs. Names of participants in a Seattle IDU cohort study who acquired HBV or HCV infection over a 12-month follow-up period were compared to a database of persons with acute hepatitis B and C reported to the health department surveillance unit over the same period. Of 2,208 IDUs enrolled in the cohort who completed a follow-up visit, 63/759 acquired HBV infection, 53/317 acquired HCV infection, and 3 subjects acquired both HBV and HCV. Of 113 cohort subjects who acquired HBV or HCV, only 2 (1.5%) cases were reported; both had acute hepatitis B. The upper 95% confidence limit for case-reporting of hepatitis C in the cohort was 5.7%, and for hepatitis B, it was 7.5%. In this study, reporting of acute hepatitis in IDUs was extremely low, raising questions regarding the use of community surveillance data to estimate underlying incidence in that population group.

Original languageEnglish (US)
Pages (from-to)579-585
Number of pages7
JournalJournal of Urban Health
Volume79
Issue number4
DOIs
StatePublished - Dec 2002

Fingerprint

HBV
Hepatitis C
Drug Users
Hepatitis B
contagious disease
drug
Injections
Infection
surveillance
Public Health Surveillance
incidence
Incidence
Population Groups
Hepatitis B virus
Information Systems
Hepacivirus
communicable disease
Hepatitis
Names
Communicable Diseases

Keywords

  • Hepatitis B
  • Hepatitis C
  • Substance use
  • Surveillance

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Cite this

Hagan, H., Snyder, N., Hough, E., Yu, T., McKeirnan, S., Boase, J., & Duchin, J. (2002). Case-reporting of acute hepatitis B and C among injection drug users. Journal of Urban Health, 79(4), 579-585. https://doi.org/10.1093/jurban/79.4.579

Case-reporting of acute hepatitis B and C among injection drug users. / Hagan, Holly; Snyder, Nadine; Hough, Eileen; Yu, Tianji; McKeirnan, Shelly; Boase, Janice; Duchin, Jeffrey.

In: Journal of Urban Health, Vol. 79, No. 4, 12.2002, p. 579-585.

Research output: Contribution to journalArticle

Hagan, H, Snyder, N, Hough, E, Yu, T, McKeirnan, S, Boase, J & Duchin, J 2002, 'Case-reporting of acute hepatitis B and C among injection drug users', Journal of Urban Health, vol. 79, no. 4, pp. 579-585. https://doi.org/10.1093/jurban/79.4.579
Hagan, Holly ; Snyder, Nadine ; Hough, Eileen ; Yu, Tianji ; McKeirnan, Shelly ; Boase, Janice ; Duchin, Jeffrey. / Case-reporting of acute hepatitis B and C among injection drug users. In: Journal of Urban Health. 2002 ; Vol. 79, No. 4. pp. 579-585.
@article{d2a40fc1587e4fbd8e7cefbea92ad21d,
title = "Case-reporting of acute hepatitis B and C among injection drug users",
abstract = "Although public health surveillance system data are widely used to describe the epidemiology of communicable disease, occurrence of hepatitis B and C virus (HBV and HCV, respectively) infections may be misrepresented by under-reporting in injection drug users (IDUs). This study was carried out to examine the relationship between HBV and HCV incidence and case-reporting of hepatitis B and C in Seattle IDUs. Names of participants in a Seattle IDU cohort study who acquired HBV or HCV infection over a 12-month follow-up period were compared to a database of persons with acute hepatitis B and C reported to the health department surveillance unit over the same period. Of 2,208 IDUs enrolled in the cohort who completed a follow-up visit, 63/759 acquired HBV infection, 53/317 acquired HCV infection, and 3 subjects acquired both HBV and HCV. Of 113 cohort subjects who acquired HBV or HCV, only 2 (1.5{\%}) cases were reported; both had acute hepatitis B. The upper 95{\%} confidence limit for case-reporting of hepatitis C in the cohort was 5.7{\%}, and for hepatitis B, it was 7.5{\%}. In this study, reporting of acute hepatitis in IDUs was extremely low, raising questions regarding the use of community surveillance data to estimate underlying incidence in that population group.",
keywords = "Hepatitis B, Hepatitis C, Substance use, Surveillance",
author = "Holly Hagan and Nadine Snyder and Eileen Hough and Tianji Yu and Shelly McKeirnan and Janice Boase and Jeffrey Duchin",
year = "2002",
month = "12",
doi = "10.1093/jurban/79.4.579",
language = "English (US)",
volume = "79",
pages = "579--585",
journal = "Journal of Urban Health",
issn = "1099-3460",
publisher = "Springer Science and Business Media Deutschland GmbH",
number = "4",

}

TY - JOUR

T1 - Case-reporting of acute hepatitis B and C among injection drug users

AU - Hagan, Holly

AU - Snyder, Nadine

AU - Hough, Eileen

AU - Yu, Tianji

AU - McKeirnan, Shelly

AU - Boase, Janice

AU - Duchin, Jeffrey

PY - 2002/12

Y1 - 2002/12

N2 - Although public health surveillance system data are widely used to describe the epidemiology of communicable disease, occurrence of hepatitis B and C virus (HBV and HCV, respectively) infections may be misrepresented by under-reporting in injection drug users (IDUs). This study was carried out to examine the relationship between HBV and HCV incidence and case-reporting of hepatitis B and C in Seattle IDUs. Names of participants in a Seattle IDU cohort study who acquired HBV or HCV infection over a 12-month follow-up period were compared to a database of persons with acute hepatitis B and C reported to the health department surveillance unit over the same period. Of 2,208 IDUs enrolled in the cohort who completed a follow-up visit, 63/759 acquired HBV infection, 53/317 acquired HCV infection, and 3 subjects acquired both HBV and HCV. Of 113 cohort subjects who acquired HBV or HCV, only 2 (1.5%) cases were reported; both had acute hepatitis B. The upper 95% confidence limit for case-reporting of hepatitis C in the cohort was 5.7%, and for hepatitis B, it was 7.5%. In this study, reporting of acute hepatitis in IDUs was extremely low, raising questions regarding the use of community surveillance data to estimate underlying incidence in that population group.

AB - Although public health surveillance system data are widely used to describe the epidemiology of communicable disease, occurrence of hepatitis B and C virus (HBV and HCV, respectively) infections may be misrepresented by under-reporting in injection drug users (IDUs). This study was carried out to examine the relationship between HBV and HCV incidence and case-reporting of hepatitis B and C in Seattle IDUs. Names of participants in a Seattle IDU cohort study who acquired HBV or HCV infection over a 12-month follow-up period were compared to a database of persons with acute hepatitis B and C reported to the health department surveillance unit over the same period. Of 2,208 IDUs enrolled in the cohort who completed a follow-up visit, 63/759 acquired HBV infection, 53/317 acquired HCV infection, and 3 subjects acquired both HBV and HCV. Of 113 cohort subjects who acquired HBV or HCV, only 2 (1.5%) cases were reported; both had acute hepatitis B. The upper 95% confidence limit for case-reporting of hepatitis C in the cohort was 5.7%, and for hepatitis B, it was 7.5%. In this study, reporting of acute hepatitis in IDUs was extremely low, raising questions regarding the use of community surveillance data to estimate underlying incidence in that population group.

KW - Hepatitis B

KW - Hepatitis C

KW - Substance use

KW - Surveillance

UR - http://www.scopus.com/inward/record.url?scp=0036955960&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036955960&partnerID=8YFLogxK

U2 - 10.1093/jurban/79.4.579

DO - 10.1093/jurban/79.4.579

M3 - Article

VL - 79

SP - 579

EP - 585

JO - Journal of Urban Health

JF - Journal of Urban Health

SN - 1099-3460

IS - 4

ER -